As COVID-19 continues to spread worldwide, the successful offline hosting of the CIIE showcases the Chinese government's confidence in its fight against the pandemic, and its impressive organizational capabilities. It further underscores the important message that China remains committed to opening itself up to the outside world, strengthening exchanges and cooperation with other countries, and sharing the fruits of trade and economic development. Through participation in the first two CIIEs, AstraZeneca has significantly benefitted from the spillover and driving effects of the CIIE to make remarkable headway in the Chinese market. This year, we will continue to harness the CIIE as a platform to introduce our innovative medicines, seek broad partnership models, and actively explore innovative healthcare solutions. We look forward to joining our global partners in driving innovation and building a two-way open healthcare ecosystem.